Search

A composite (ZS–UiO–66–NH 2) zirconium crosslinked sodium alginate gel beads (ZS)–metal–organic skeleton (UiO–66–NH 2) were prepared in this study through in–situ growth under simple, green and mild conditions for removal of the salicylic acid (SA) and sulfosalicylic acid (SSA) from water. The physicochemical properties of ZS–UiO–66–NH 2 were characterized using various analytical methods. The influencing factors in the adsorption process including pH of solution, amount of adsorbent, coexisting ions, adsorption time, reaction temperature and equilibrium concentration of SA/SSA were performed in batch adsorption. The experimental results indicated that ZS–UiO–66–NH 2 had high stability and could achieve efficient adsorption of SA/SSA in broad pH range (2–9) and salinity (0–0.2 mol·L−1). SA and SSA adsorbed on the composite at 293 K reached high values of 193 and 167 mg·g−1 from Langmuir model, respectively. Kinetic and isotherm studies demonstrated that the adsorption processes were mainly multilayer heterogeneous chemisorption. Thermodynamic data manifested that the two processes were exothermic and spontaneous with increasing entropy. ZS–UiO–66–NH 2 can effectively remove SA/SSA from simulated wastewater under different pH and can be reused after elution with a NaHCO 3 solution (5 mmol·L−1). The ZS–UiO–66–NH 2 composite has great potential for removing SA/SSA from actual water bodies. • The preparation process of ZS–UiO–66–NH 2 is simple, green and economical. • ZS–UiO–66–NH 2 has high adsorption performance for SA and SSA. • The two adsorption processes of SA and SSA show wide pH application range. • ZS–UiO–66–NH 2 has ideal recycling performance. [ABSTRACT FROM AUTHOR]

Hemorrhage is a potentially life-threatening emergency that can occur at any time or place. Whether traumatic, congenital, surgical, disease-related, or drug-induced, bleeding can lead to severe complications or death. Therefore, the development of efficient hemostatic materials is critical. However, the results and prognosis demonstrated by clinical means of hemostasis do not reach expectations. With the development of technology, novel hemostatic materials have been developed from polysaccharides (chitosan, hyaluronic acid, alginate, cellulose, cyclodextrins, starch, dextran, and carrageenan), peptides (self-assembling peptides), and proteins (silk fibroin, collagen, gelatin, keratin, and thrombin). These new materials exhibit high hemostatic efficacy due to the enhancement or interaction of various hemostatic mechanisms. The main forms include adhesives, sealants, bandages, hemostatic powders, and hemostatic sponges. This article introduces the clotting process and principles of hemostatic methods and reviews the research on polysaccharide-, peptide-, and protein-based hemostatic materials in the last five years. The design ideas and hemostatic principles of polysaccharide-, peptide-, and protein-based hemostatic materials are mainly introduced. Finally, we summarize material designs, advantages, disadvantages, and challenges regarding hemostatic materials. [ABSTRACT FROM AUTHOR]